Semaglutide is the active ingredient in the weight loss medication Wegovy and the diabetes drugs Ozempic and Rybelsus, which are sometimes taken off-label for weight loss.

In a study looking at semaglutide, those who took a weekly dose of 2.4 mg for weight loss only — not for those with diabetes — lost an average body weight of 14.9% compared to the 2.4% in the ...

A head-to-head trial found that tirzepatide led to significantly greater weight loss and waist reduction than semaglutide in adults with obesity but without diabetes. Over 72 weeks, tirzepatide ...

Alternatives to weekly injections of weight-loss drugs may be on the way. A monthly dose of a new drug called MariTide helped ...

The following is a summary of “Oral semaglutide for the treatment of obesity: a retrospective real-world study,” published in the May 2025 issue of Frontiers in Endocrinology by Krajnc et al.

In real-world cohort, percentage weight reduction at 1 year was 3.6%, 6.8%, and 11.9% with early and late discontinuation and nondiscontinuation, respectively.

This ShedRx 4-Week Semaglutide Weight Loss Program with Consultation is on sale right in time for summer. By Stack Commerce. Published Apr 28, 2025 7:00 AM EDT. Stack Commerce.

A new study involving nearly 1.7 million patients suggests that semaglutide — a drug that mimics a gut hormone to lower blood sugar and aid weight loss — could significantly cut dementia risk in older ...

Weight loss treatment combining personalized semaglutide with intensive behavioral therapy (IBT) yields weight loss similar to that reported in confirmatory trials, with a lower dose of medication.